Developing a new scheme to more efficiently solve quantum chemistry problems.

CACTUS provides AI-powered cheminformatics for autonomous science.

PNNL's new energy storage facility now houses the Lab's vehicle battery research programs, which have more lab space and a slew of new capabilities.

Pacific Northwest National Laboratory researchers developed a new theoretical method for studying highly correlated systems.

PNNL scientists use proteomics to unveil how high-density lipoproteins protect against cholesterol accumulation in the artery wall.

Nineteen PNNL-affiliated researchers have been named to Clarivate’s 2024 list of the world's most highly cited researchers.

In a recent publication in Nature Communications, a team of researchers presents a mathematical theory to address the challenge of barren plateaus in quantum machine learning.

Early life exposure to polycyclic aromatic hydrocarbons (PAHs), found in smoke, has been linked to developmental problems. To study the impacts of these pollutants, PAH metabolism in infants and adults were compared.

PMedIC, the PNNL and OHSU joint research collaboration, contributes to student success and impact in biomedicine.

A new approach validates quantum algorithms for low-energy nuclear physics applications

A new quantum algorithm speeds up simulations of coupled oscillator dynamics.

Data reveals mechanisms in our bodies that can help us fight viral pathogenesis.

In a new approach, quantum flow algorithms are used to simulate many-body systems on quantum computers and effectively describe chemical processes.

Pacific Northwest may face increase in summer heat-dome-like stationary waves.

Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.

A combined experimental and theoretical study identified multiple interactions that affect the performance of redox-active metal oxides for potential electrochemical separation and quantum computing applications.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A new approach broadens the reach of quantum computers to previously challenging systems.